Veracyte (VCYT) Tops Q3 Earnings and Revenue Estimates
Portfolio Pulse from
Veracyte (VCYT) reported Q3 earnings of $0.19 per share, surpassing the Zacks Consensus Estimate of $0.02 per share, and improved from a loss of $0.03 per share a year ago.
November 07, 2024 | 12:30 am
News sentiment analysis
Sort by:
Descending
POSITIVE IMPACT
Veracyte reported strong Q3 earnings of $0.19 per share, significantly beating the Zacks Consensus Estimate of $0.02 and improving from a loss last year.
Veracyte's Q3 earnings exceeded expectations and showed a significant improvement from the previous year, likely boosting investor confidence and positively impacting the stock price in the short term.
CONFIDENCE 95
IMPORTANCE 90
RELEVANCE 100